METACARE CO., Ltd. (KRX:118000)
South Korea · Delayed Price · Currency is KRW 1,413.00
-19.00 (-1.33%)
Last updated: Aug 12, 2026, 2:11 PM KST
METACARE CO. Market Cap
METACARE CO. has a market cap or net worth of 24.56 billion as of August 12, 2026. Its market cap has decreased by -55.59% in one year.
Market Cap
24.56B
Enterprise Value
75.98B
Revenue
36.95B
Ranking
n/a
PE Ratio
26.36
Stock Price
1,413.00
ChartMarket Cap Chart
Since January 4, 2010, METACARE CO.'s market cap has decreased from 39.82B to 24.56B, a decrease of -38.31%. That is a compound annual growth rate of -2.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 24.56B | -53.11% |
| Dec 30, 2025 | 52.39B | 12.75% |
| Dec 30, 2024 | 46.47B | -18.64% |
| Dec 28, 2023 | 57.11B | 29.66% |
| Dec 29, 2022 | 44.05B | -64.01% |
| Dec 30, 2021 | 122.39B | -14.64% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 72.63T |
| Celltrion | 46.09T |
| ALTEOGEN | 24.23T |
| Samsung Epis Holdings | 10.48T |
| Gencurix | 40.18B |
| HASS Corp. | 34.23B |
| BCWORLD PHARM. | 32.69B |
| Tdspharm | 30.91B |